Moreover, abnormal NAD+ metabolism and increased NAD consumption by NAD-consuming enzymes (PARPs and CD38) have been described in IBD [69], suggesting a link between NAD metabolism and IBD. Here, CD38 is linked to irritable bowel syndrome.